Satiety, the physiologic processes that combine to bring about the
cessation of a meal, is controlled in part by intestinal peptide secretion.
The effects of cholecystokinin, glucagon-like peptide I, peptide YY, and
apolipoprotein A-IV are described.
Greenberg D. Intestinal satiety. In: Smith GP, ed. Satiation
From Gut to Brain. New York, NY: Oxford University Press;1998
: 40-70.
3.
Liddle RA. Cholecystokinin. In: Dockray GJ, Walsh JH, eds.Gut Peptides.
New York, NY: Raven Press; 1994:175
-216.
4.
Reidelberger RD, Hernandez J, Fritzsch B, Hulce M. Abdominal vagal
mediation of the satiety effects of CCK in rats. Am J Physiol Regul
Integr Comp Physiol.2004;286:R1005
-R1012.
5.
Gibbs J, Young RC, Smith GP. Cholecystokinin elicits satiety in
rats with open gastric fistulas. Nature.1973
;245:323
-325.
6.
Schwartz GJ, Moran TH. Duodenal nutrient exposure elicits
nutrient-specific gut motility and vagal afferent signals in rat. Am J
Physiol.1998;274:R1236
-R1242.
7.
Barrachina MD, Martinez V, Wang L, Wei JY, Tache Y. Synergistic
interaction between leptin and cholecystokinin to reduce short-term food
intake in lean mice. Proc Natl Acad Sci U S A.1997
;94:10455
-10460.
8.
Morton GJ, Blevins JE, Williams DL, et al. Leptin action in the
forebrain regulates the hindbrain response to satiety signals. J Clin
Invest.2005;115:703
-710.
9.
D'Alessio DA, Vahl TP. Glucagon-like peptide 1: evolution of an
incretin into a treatment for diabetes. Am J Physiol Endocrinol
Metab.2004;286:E882
-E890.
10.
Kinzig KP, D'Alessio DA, Seeley RJ. The diverse roles of specific
GLP-1 receptors in the control of food intake and the response to visceral
illness. J Neurosci.2002
;22:10470
-10476.
11.
Drucker DJ. The biology of incretin hormones. Cell
Metab.2006;3:153
-165.
12.
Williams DL, Baskin DG, Schwartz MW. Leptin regulation of the
anorexic response to glucagon-like peptide-1 receptor stimulation.Diabetes.2006;55:3387
-3393.
13.
Seeley RJ, Blake K, Rushing PA, et al. The role of CNS
glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral
illness effects of lithium chloride. J Neurosci.2000
;20:1616
-1621.
14.
Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36)
physiologically inhibits food intake. Nature.2002
;418:650
-654.
15.
Halatchev IG, Cone RD. Peripheral administration of PYY(3-36)
produces conditioned taste aversion in mice. Cell Metab.2005
;1:159
-168.
16.
Moran TH, Smedh U, Kinzig KP, Scott KA, Knipp S, Ladenheim EE.
Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in
food intake in rhesus monkeys. Am J Physiol Regul Integr Comp
Physiol.2005;288:R384
-R388.
17.
Degen L, Oesch S, Casanova M, et al. Effect of peptide YY3-36 on
food intake in humans. Gastroenterology.2005
;129:1430
-1436.
18.
Tso P, Liu M, Kalogeris TJ. The role of apolipoprotein A-IV in food
intake regulation. J Nutr.1999
;129:1503
-1506.
19.
Fujimoto K, Fukagawa K, Sakata T, Tso P. Suppression of food intake
by apolipoprotein A-IV is mediated through the central nervous system in rats.J Clin Invest.1993;91:1830
-1833.
